Accelleron Industries raises revenue guidance for 2025

Accelleron Industries raises revenue guidance for 2025

Accelleron Industries, a leading provider of innovative medical technologies, has announced an upward revision in its revenue guidance for the full year 2025. The company expects its revenue to be between $365 million and $375 million, an increase from its previous guidance of $395 million to $405 million. This revision reflects the company's positive performance in the second quarter of 2025, with revenue projected to be between $95.4 million and $95.5 million [1].

The revision in revenue guidance comes amidst a challenging economic environment, with continued market weakness and persistent uncertainty surrounding the U.S. economic outlook. However, Accelleron Industries' management remains optimistic about the company's financial prospects and expects to deliver strong results in the coming quarters.

The company will hold a conference call on July 30, 2025, at 8:30 a.m. Eastern Time to discuss its second-quarter 2025 financial results. The call will be webcast live and a replay will be available for 90 days on the company's website [1].

References:
1. [1] https://www.morningstar.com/news/pr-newswire/20250710ln27115/inmode-to-report-second-quarter-2025-financial-results-and-hold-conference-call-on-july-30-expects-q2-revenue-between-954m-955m-decreases-full-year-2025-revenue-guidance-to-be-between-365m-375m